Emeramide

Emeramide

SCHEMBL3077248

O=C(NCCS)c1cccc(C(=O)NCCS)c1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.62
HDAC2 Q92769 5/20 0.56
HDAC8 Q9BY41 5/20 0.56
HDAC6 Q9UBN7 5/20 0.56
HDAC3 O15379 3/20 0.56
HDAC4 P56524 3/20 0.56
HDAC1 Q13547 3/20 0.56
HDAC7 Q8WUI4 3/20 0.56
HDAC10 Q969S8 3/20 0.56
HDAC11 Q96DB2 3/20 0.56
HDAC9 Q9UKV0 3/20 0.56
HDAC5 Q9UQL6 3/20 0.56
KMT2A Q03164 2/20 0.55
GAA P10253 1/20 0.55
HSD17B10 Q99714 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6332819 0.91 SMN1; SMN2 (0.54) SMN1; SMN2HDAC2HDAC8HDAC6HDAC3
Benzene SCHEMBL17784170 0.88 HDAC3 (0.55) SMN1; SMN2HDAC2HDAC8HDAC6HDAC3
SCHEMBL12189305 0.87 HDAC6 (0.48) SMN1; SMN2HDAC2HDAC8HDAC6HDAC3
SCHEMBL3122604 0.86 HDAC3 (0.73) SMN1; SMN2HDAC2HDAC8HDAC6HDAC3
SCHEMBL12308200 0.83 HDAC1 (0.58) HDAC2HDAC8HDAC6HDAC3HDAC4
SCHEMBL12308240 0.82 HDAC3 (0.67) HDAC2HDAC8HDAC6HDAC3HDAC4
SCHEMBL19692578 0.82 RAB9A (0.63) KMT2AGAANPC1RAB9AMEN1
SCHEMBL3319225 0.82 SMN1; SMN2 (0.65) SMN1; SMN2HDAC2HDAC8HDAC6HDAC3
SCHEMBL12308117 0.80 KDM4E (0.64) SMN1; SMN2HDAC2HDAC8HDAC6HDAC3
SCHEMBL285298 0.80 SMN1; SMN2 (0.62) SMN1; SMN2HDAC2HDAC8HDAC6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028685-A1 Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids UNIV COLORADO REGENTS (US) 2026-01-29 US claimed
EP-3829715-B1 QUATERNARY AMMONIUM SALTS OF NICOTINIC ACID AND NICOTINAMIDE MONONUCLOETIDES AND RIBOSIDES AS ANTI-AGING AGENTS Jumpstart Fertility Pty Ltd (AU) 2025-12-03 EP claimed
EP-3794005-B1 INORGANIC SALTS OF NICOTINIC ACID MONONUCLEOTIDE AS ANTI-AGING AGENTS Jumpstart Fertility Pty Ltd (AU) 2025-10-22 EP claimed
CN-120147904-A Dead wood quantity counting and positioning method based on orthographic video of unmanned aerial vehicle 福建师范大学 2025-06-13 CN claimed
CN-112803595-B High-reliability intelligent power distribution control switch with breakpoint recovery function and method 桂林航天工业学院 2025-01-28 CN claimed
CN-113498416-B Inorganic salts of nicotinic acid mononucleotide as anti-aging agents 江普斯塔特生育有限公司 2024-12-06 CN claimed
WO-2024218296-A1 COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF LEUCINE-RICH REPEAT KINASE 2 (LRRK2) INHIBITORS H. LUNDBECK A/S (DK) 2024-10-24 WO claimed
CN-118329812-A Method and kit for synthesizing and detecting mercury ions by using seedless gold nano material 上海师范大学 2024-07-12 CN claimed
CN-117994677-A Visual large language model construction method for multi-source ship remote sensing image interpretation 北京理工大学 2024-05-07 CN claimed
CN-109101707-B Method for simulating shallow lake ecosystem model 广州资源环保科技股份有限公司 2023-11-10 CN claimed
CN-114835192-A Composite extracting agent, preparation method and application thereof in sewage treatment 山东微观生态研究中心有限公司 2022-08-02 CN claimed
CN-112358226-B Stainless steel slag curing agent and preparation method thereof 桂林理工大学 2022-02-08 CN claimed
US-10008749-B2 Lithium ion battery GM Global Technology Operations LLC (US) 2018-06-26 US claimed
US-20170365882-A1 LITHIUM ION BATTERY GM Global Technology Operations LLC 2017-12-21 US claimed
US-20170365883-A1 LITHIUM ION BATTERY BAR ILAN UNIVERSITY (IL) 2017-12-21 US claimed
WO-2026107213-A1 SYSTEMS AND METHODS FOR AUDIO WATERMARKING DOLBY LABORATORIES LICENSING CORPORATION (US) 2026-05-21 WO disclosed
WO-2026102534-A1 MEMORY-AUGMENTED DETECTION WAABI CANADA, INC. (CA) 2026-05-21 WO disclosed
US-20100227812-A1 METHOD OF SUPPLEMENTING THE DIET AND AMELIORATING OXIDATIVE STRESS EMERAMED LIMITED (IE) 2010-09-09 US disclosed
US-20100227812-A1 METHOD OF SUPPLEMENTING THE DIET AND AMELIORATING OXIDATIVE STRESS EMERAMED LIMITED (IE) 2010-09-09 US disclosed
US-20100227812-A1 METHOD OF SUPPLEMENTING THE DIET AND AMELIORATING OXIDATIVE STRESS EMERAMED LIMITED (IE) 2010-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028685-A1 Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids RNASEH1, ACE2, DDX42 SMN1; SMN2 512/4885HDAC2 2382/4885HDAC8 3191/4885
US-20100227812-A1 METHOD OF SUPPLEMENTING THE DIET AND AMELIORATING OXIDATIVE STRESS GPX4, GPX1, SOD1 SMN1; SMN2 2092/4885HDAC2 99/4885HDAC8 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.